2013
DOI: 10.1016/j.imbio.2013.04.018
|View full text |Cite
|
Sign up to set email alerts
|

Histone deacetylase inhibition by Japanese encephalitis virus in monocyte/macrophages: A novel viral immune evasion strategy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
11
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 37 publications
1
11
0
1
Order By: Relevance
“…In a recent study we had demonstrated that at early time points (6, 12 and 24 h) there is no significant alterations in the expression of MHC-1 or the costimulatory molecules CD80 and CD86 on the surface of JEV-infected macrophages compared to non-infected controls [28]. Hence, it may be assumed that during early infection there is no viral antigen presentation by infected macrophages, and thus there should be no involvement of the adaptive immune system in viral clearance.…”
Section: Discussionmentioning
confidence: 91%
“…In a recent study we had demonstrated that at early time points (6, 12 and 24 h) there is no significant alterations in the expression of MHC-1 or the costimulatory molecules CD80 and CD86 on the surface of JEV-infected macrophages compared to non-infected controls [28]. Hence, it may be assumed that during early infection there is no viral antigen presentation by infected macrophages, and thus there should be no involvement of the adaptive immune system in viral clearance.…”
Section: Discussionmentioning
confidence: 91%
“…This viral-induced redistribution may either interfere with the host epigenetic status or favour ASFV replication as reported for other viral infections [ 69 ]. Even though the role of HDAC6 in ASFV cytoplasmic factories formation is still to be proven [ 70 ], our findings on class I HDACs raise the possibility of using HDAC I inhibitors to disrupt ASFV infection, as demonstrated in other viral infections [ 71 , 72 ].…”
Section: Discussionmentioning
confidence: 95%
“…Finally, transcription factors such as interferon regulated factor 3 (IRF3)/IRF7 [ 36 , 75 , 86 , 90 92 ], activator protein 1 [ 87 ] and nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) [ 38 , 39 , 70 , 73 , 75 , 87 ] are found to be implicated during JEV infection. In rat microglia, inhibition of NF-κB abrogates the production of TNF-α and IL-1β by rat microglia [ 88 ].…”
Section: Molecular Components Of Jev Recognitionmentioning
confidence: 99%
“…Importantly, the activity of inflammatory components have also been described to depend on the janus kinase-signal transducer and activator of transcription (JAK-STAT) signalling pathway in JEV infection. This requires the activation of STAT1 [ 24 , 36 , 92 ] and the expression of IFN-dependent and IFN-independent IFN-stimulated genes [ 36 , 37 ].…”
Section: Molecular Components Of Jev Recognitionmentioning
confidence: 99%